T1	B-Protein	0	2	IL	IL	B-NP	NN	B-protein	5	SUB	B-protein
T1	I-Protein	2	3	-	-	B-NP	HYPH	I-protein	1	NMOD	I-protein
T1	I-Protein	3	4	2	2	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	4	5	-	-	I-NP	HYPH	O	1	P	O
O	O	5	12	induced	induce	I-NP	VBN	O	6	NMOD	O
O	O	13	19	growth	growth	I-NP	NN	O	0	ROOT	O
O	O	20	22	of	of	B-PP	IN	O	6	NMOD	O
T19	B-Entity	23	26	CD8	CD8	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	26	27	+	+	O	SYM	O	14	NMOD	O
O	O	28	29	T	T	B-NP	NN	B-cell_type	14	NMOD	B-cell_type
O	O	30	34	cell	cell	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	35	49	prolymphocytic	prolymphocytic	I-NP	JJ	I-cell_type	14	NMOD	I-cell_type
O	O	50	58	leukemia	leukemia	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	59	64	cells	cell	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	65	73	mediated	mediate	B-VP	VBN	O	14	NMOD	O
O	O	74	76	by	by	B-PP	IN	O	15	VMOD	O
T20	B-Entity	77	79	NF	NF	B-NP	NN	B-protein	19	NMOD	B-protein
T20	I-Entity	79	80	-	-	I-NP	HYPH	I-protein	19	NMOD	I-protein
T20	I-Entity	80	86	kappaB	kappaB	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	87	96	induction	induction	I-NP	NN	O	27	NMOD	O
O	O	97	100	and	and	I-NP	CC	O	27	NMOD	O
T2	B-Protein	101	103	IL	IL	I-NP	NN	B-protein	27	NMOD	B-protein
T2	I-Protein	103	104	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T2	I-Protein	104	105	2	2	I-NP	CD	I-protein	27	NMOD	I-protein
T2	I-Protein	106	114	receptor	receptor	I-NP	NN	I-protein	27	NMOD	I-protein
T2	I-Protein	115	120	alpha	alpha	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	121	131	expression	expression	I-NP	NN	O	16	PMOD	O
O	O	131	132	.	.	O	.	O	6	P	O

O	O	134	137	The	The	B-NP	DT	O	2	NMOD	O
O	O	138	145	binding	binding	I-NP	NN	O	19	SUB	O
O	O	146	148	of	of	B-PP	IN	O	2	NMOD	O
T3	B-Protein	149	160	interleukin	interleukin	B-NP	NN	B-protein	3	PMOD	B-protein
T3	I-Protein	160	161	-	-	B-NP	HYPH	O	4	P	O
T3	I-Protein	161	162	2	2	I-NP	CD	O	4	NMOD	O
O	O	163	164	(	(	O	(	O	11	DEP	O
T4	B-Protein	164	166	IL	IL	B-NP	NN	B-protein	11	DEP	B-protein
T4	I-Protein	166	167	-	-	O	HYPH	I-protein	8	NMOD	I-protein
T4	I-Protein	167	168	2	2	B-NP	CD	I-protein	8	NMOD	I-protein
O	O	168	169	)	)	O	)	O	4	NMOD	O
O	O	170	172	to	to	B-PP	TO	O	2	NMOD	O
O	O	173	176	its	its	B-NP	PRP$	O	14	NMOD	O
O	O	177	185	receptor	receptor	I-NP	NN	O	12	PMOD	O
O	O	186	188	on	on	B-PP	IN	O	14	NMOD	O
O	O	189	195	normal	normal	B-NP	JJ	O	18	NMOD	O
O	O	196	197	T	T	I-NP	NN	B-cell_type	18	NMOD	B-cell_type
O	O	198	203	cells	cell	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	204	211	induces	induce	B-VP	VBZ	O	0	ROOT	O
O	O	212	219	nuclear	nuclear	B-NP	JJ	O	21	NMOD	O
O	O	220	230	expression	expression	I-NP	NN	O	50	NMOD	O
O	O	231	233	of	of	B-PP	IN	O	21	NMOD	O
T21	B-Entity	234	241	nuclear	nuclear	B-NP	JJ	B-protein	25	NMOD	B-protein
T21	I-Entity	242	248	factor	factor	I-NP	NN	I-protein	25	NMOD	I-protein
T21	I-Entity	249	255	kappaB	kappaB	I-NP	NN	I-protein	22	PMOD	I-protein
O	O	256	257	(	(	O	(	O	30	DEP	O
T22	B-Entity	257	259	NF	NF	B-NP	NN	B-protein	29	NMOD	B-protein
T22	I-Entity	259	260	-	-	B-NP	HYPH	I-protein	29	P	I-protein
T22	I-Entity	260	266	kappaB	kappaB	I-NP	NN	I-protein	30	DEP	I-protein
O	O	266	267	)	)	O	)	O	25	NMOD	O
O	O	267	268	,	,	O	,	O	50	P	O
O	O	269	279	activation	activation	B-NP	NN	O	50	NMOD	O
O	O	280	282	of	of	B-PP	IN	O	32	NMOD	O
O	O	283	286	the	the	B-NP	DT	O	46	NMOD	O
T5	B-Protein	287	289	IL	IL	I-NP	NN	B-DNA	46	NMOD	B-DNA
T5	I-Protein	289	290	-	-	O	HYPH	I-DNA	46	NMOD	I-DNA
T5	I-Protein	290	291	2	2	B-NP	CD	I-DNA	46	NMOD	I-DNA
T5	I-Protein	292	300	receptor	receptor	I-NP	NN	I-DNA	46	NMOD	I-DNA
T5	I-Protein	301	302	(	(	O	(	I-DNA	43	DEP	I-DNA
T5	I-Protein	302	304	IL	IL	B-NP	NN	I-DNA	42	NMOD	I-DNA
T5	I-Protein	304	305	-	-	B-NP	HYPH	I-DNA	42	P	I-DNA
T5	I-Protein	305	307	2R	2R	I-NP	NN	I-DNA	43	DEP	I-DNA
T5	I-Protein	307	308	)	)	O	)	I-DNA	46	NMOD	I-DNA
T5	I-Protein	309	314	alpha	alpha	B-NP	NN	I-DNA	46	NMOD	I-DNA
T5	I-Protein	315	320	chain	chain	I-NP	NN	I-DNA	46	NMOD	I-DNA
O	O	321	325	gene	gene	I-NP	NN	I-DNA	33	PMOD	I-DNA
O	O	325	326	,	,	O	,	O	50	P	O
O	O	327	330	and	and	O	CC	O	50	NMOD	O
O	O	331	335	cell	cell	B-NP	NN	O	50	NMOD	O
O	O	336	349	proliferation	proliferation	I-NP	NN	O	19	OBJ	O
O	O	349	350	.	.	O	.	O	19	P	O

O	O	351	353	In	In	B-PP	IN	O	29	VMOD	O
O	O	354	357	the	the	B-NP	DT	O	4	NMOD	O
O	O	358	365	present	present	I-NP	JJ	O	4	NMOD	O
O	O	366	371	study	study	I-NP	NN	O	1	PMOD	O
O	O	371	372	,	,	O	,	O	29	P	O
O	O	373	376	the	the	B-NP	DT	O	7	NMOD	O
O	O	377	381	role	role	I-NP	NN	O	29	SUB	O
O	O	382	384	of	of	B-PP	IN	O	7	NMOD	O
O	O	385	387	IL	IL	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	387	388	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
O	O	388	390	2R	2R	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	391	400	signaling	signaling	I-NP	NN	O	8	PMOD	O
O	O	401	403	in	in	B-PP	IN	O	7	NMOD	O
O	O	404	407	the	the	B-NP	DT	O	15	NMOD	O
O	O	408	414	growth	growth	I-NP	NN	O	13	PMOD	O
O	O	415	417	of	of	B-PP	IN	O	15	NMOD	O
T23	B-Entity	418	421	CD8	CD8	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	421	422	+	+	O	SYM	O	22	NMOD	O
O	O	423	424	T	T	B-NP	NN	O	22	NMOD	O
O	O	425	429	cell	cell	I-NP	NN	O	22	NMOD	O
O	O	430	444	prolymphocytic	prolymphocytic	I-NP	JJ	O	22	NMOD	O
O	O	445	453	leukemia	leukemia	I-NP	NN	O	28	NMOD	O
O	O	454	455	(	(	O	(	O	27	DEP	O
O	O	455	456	T	T	B-NP	NN	O	26	NMOD	O
O	O	456	457	-	-	I-NP	HYPH	O	26	P	O
O	O	457	460	PLL	PLL	I-NP	NN	O	27	DEP	O
O	O	460	461	)	)	I-NP	)	O	22	NMOD	O
O	O	462	467	cells	cell	I-NP	NNS	O	16	PMOD	O
O	O	468	471	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	472	476	been	be	I-VP	VBN	O	29	VC	O
O	O	477	489	investigated	investigate	I-VP	VBN	O	30	VC	O
O	O	489	490	.	.	O	.	O	29	P	O

O	O	491	495	Flow	Flow	B-NP	NN	O	2	NMOD	O
O	O	496	505	cytometry	cytometry	I-NP	NN	O	3	SUB	O
O	O	506	514	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	515	519	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	520	527	primary	primary	B-NP	JJ	B-cell_type	7	NMOD	B-cell_type
O	O	528	536	leukemia	leukemia	I-NP	NN	I-cell_type	7	NMOD	I-cell_type
O	O	537	542	cells	cell	I-NP	NNS	I-cell_type	28	SUB	I-cell_type
O	O	543	547	from	from	B-PP	IN	O	7	NMOD	O
O	O	548	549	a	a	B-NP	DT	O	10	NMOD	O
O	O	550	557	patient	patient	I-NP	NN	O	8	PMOD	O
O	O	558	562	with	with	B-PP	IN	O	10	NMOD	O
T24	B-Entity	563	566	CD8	CD8	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	566	567	+	+	I-NP	SYM	O	23	NMOD	O
O	O	568	569	T	T	I-NP	NN	O	23	NMOD	O
O	O	569	570	-	-	I-NP	HYPH	O	23	NMOD	O
O	O	570	573	PLL	PLL	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	574	583	expressed	express	I-NP	VBN	O	23	NMOD	O
T6	B-Protein	584	586	IL	IL	I-NP	NN	B-protein	23	NMOD	B-protein
T6	I-Protein	586	587	-	-	I-NP	HYPH	I-protein	23	NMOD	I-protein
T6	I-Protein	587	594	2Ralpha	2Ralpha	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	595	598	and	and	I-NP	CC	I-protein	23	NMOD	I-protein
T7	B-Protein	599	603	beta	beta	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	604	610	chains	chain	I-NP	NNS	I-protein	11	PMOD	I-protein
O	O	610	611	,	,	O	,	O	28	P	O
O	O	612	615	and	and	O	CC	O	28	VMOD	O
O	O	616	619	the	the	B-NP	DT	O	27	NMOD	O
O	O	620	625	cells	cell	I-NP	NNS	O	28	SUB	O
O	O	626	632	showed	show	B-VP	VBD	O	4	SBAR	O
O	O	633	634	a	a	B-NP	DT	O	31	NMOD	O
O	O	635	648	proliferative	proliferative	I-NP	JJ	O	31	NMOD	O
O	O	649	657	response	response	I-NP	NN	O	34	NMOD	O
O	O	658	661	and	and	O	CC	O	34	NMOD	O
O	O	662	664	an	an	B-NP	DT	O	34	NMOD	O
O	O	665	673	increase	increase	I-NP	NN	O	28	OBJ	O
O	O	674	676	in	in	B-PP	IN	O	34	NMOD	O
T8	B-Protein	677	679	IL	IL	B-NP	NN	B-protein	39	NMOD	B-protein
T8	I-Protein	679	680	-	-	B-NP	HYPH	I-protein	39	NMOD	I-protein
T8	I-Protein	680	687	2Ralpha	2Ralpha	I-NP	NN	I-protein	39	NMOD	I-protein
O	O	688	698	expression	expression	I-NP	NN	O	35	PMOD	O
O	O	699	701	on	on	B-PP	IN	O	34	NMOD	O
O	O	702	709	culture	culture	B-NP	NN	O	40	PMOD	O
O	O	710	714	with	with	B-PP	IN	O	41	NMOD	O
O	O	715	725	exogeneous	exogeneous	B-NP	JJ	O	42	PMOD	O
T9	B-Protein	726	728	IL	IL	I-NP	NN	B-protein	45	NMOD	B-protein
T9	I-Protein	728	729	-	-	B-NP	HYPH	I-protein	43	NMOD	I-protein
T9	I-Protein	729	730	2	2	I-NP	CD	I-protein	43	NMOD	I-protein
O	O	730	731	.	.	O	.	O	3	P	O

O	O	732	740	Northern	Northern	B-NP	NN	O	3	NMOD	O
O	O	741	745	blot	blot	I-NP	NN	O	3	NMOD	O
O	O	746	754	analysis	analysis	I-NP	NN	O	4	SUB	O
O	O	755	761	failed	fail	B-VP	VBD	O	0	ROOT	O
O	O	762	764	to	to	I-VP	TO	O	6	VMOD	O
O	O	765	771	detect	detect	I-VP	VB	O	4	VMOD	O
T10	B-Protein	772	774	IL	IL	B-NP	NN	B-RNA	10	NMOD	B-RNA
T10	I-Protein	774	775	-	-	O	HYPH	I-RNA	7	NMOD	I-RNA
T10	I-Protein	775	776	2	2	B-NP	CD	I-RNA	10	NMOD	I-RNA
O	O	777	781	mRNA	mRNA	I-NP	NN	I-RNA	6	OBJ	I-RNA
O	O	781	782	,	,	O	,	O	4	P	O
O	O	783	793	suggesting	suggest	B-VP	VBG	O	4	VMOD	O
O	O	794	798	that	that	B-SBAR	IN	O	12	VMOD	O
T11	B-Protein	799	801	IL	IL	B-NP	NN	B-protein	17	SUB	B-protein
T11	I-Protein	801	802	-	-	O	HYPH	I-protein	14	NMOD	I-protein
T11	I-Protein	802	803	2	2	B-NP	CD	I-protein	14	NMOD	I-protein
O	O	804	807	may	may	B-VP	MD	O	13	SBAR	O
O	O	808	811	act	act	I-VP	VB	O	17	VC	O
O	O	812	814	in	in	B-PP	IN	O	18	VMOD	O
O	O	815	816	a	a	B-NP	DT	O	22	NMOD	O
O	O	817	826	paracrine	paracrine	I-NP	JJ	O	22	NMOD	O
O	O	827	833	manner	manner	I-NP	NN	O	19	PMOD	O
O	O	834	836	in	in	B-ADVP	FW	O	18	VMOD	O
O	O	837	841	vivo	vivo	I-ADVP	FW	O	23	AMOD	O
O	O	841	842	.	.	O	.	O	4	P	O

O	O	843	858	Electrophoretic	Electrophoretic	B-NP	JJ	O	5	NMOD	O
O	O	859	867	mobility	mobility	I-NP	NN	O	5	NMOD	O
O	O	867	868	-	-	I-NP	HYPH	O	5	NMOD	O
O	O	868	873	shift	shift	I-NP	NN	O	5	NMOD	O
O	O	874	880	assays	assay	I-NP	NNS	O	6	SUB	O
O	O	881	889	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	890	894	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	895	906	recombinant	recombinant	B-NP	JJ	O	12	SUB	O
T12	B-Protein	907	909	IL	IL	I-NP	NN	B-protein	10	NMOD	B-protein
T12	I-Protein	909	910	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T12	I-Protein	910	911	2	2	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	912	921	increased	increase	I-NP	VBN	O	17	NMOD	O
T25	B-Entity	922	924	NF	NF	I-NP	NN	B-protein	15	NMOD	B-protein
T25	I-Entity	924	925	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T25	I-Entity	925	931	kappaB	kappaB	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	932	939	binding	binding	I-NP	NN	O	17	NMOD	O
O	O	940	948	activity	activity	I-NP	NN	O	30	SUB	O
O	O	949	951	in	in	B-PP	IN	O	17	NMOD	O
O	O	952	959	nuclear	nuclear	B-NP	JJ	O	20	NMOD	O
O	O	960	968	extracts	extract	I-NP	NNS	O	18	PMOD	O
O	O	969	971	of	of	B-PP	IN	O	20	NMOD	O
O	O	972	975	the	the	B-NP	DT	O	24	NMOD	O
O	O	976	984	leukemia	leukemia	I-NP	NN	B-cell_type	24	NMOD	B-cell_type
O	O	985	990	cells	cell	I-NP	NNS	I-cell_type	21	PMOD	I-cell_type
O	O	990	991	,	,	O	,	O	30	P	O
O	O	992	995	and	and	O	CC	O	30	VMOD	O
O	O	996	1004	Northern	Northern	B-NP	NN	O	29	NMOD	O
O	O	1005	1009	blot	blot	I-NP	NN	O	29	NMOD	O
O	O	1010	1018	analysis	analysis	I-NP	NN	O	30	SUB	O
O	O	1019	1025	showed	show	B-VP	VBD	O	7	SBAR	O
O	O	1026	1030	that	that	B-SBAR	IN	O	30	VMOD	O
T13	B-Protein	1031	1033	IL	IL	B-NP	NN	B-protein	35	SUB	B-protein
T13	I-Protein	1033	1034	-	-	B-NP	HYPH	I-protein	32	NMOD	I-protein
T13	I-Protein	1034	1035	2	2	I-NP	CD	I-protein	32	NMOD	I-protein
O	O	1036	1045	increased	increase	B-VP	VBD	O	31	SBAR	O
O	O	1046	1049	the	the	B-NP	DT	O	37	NMOD	O
O	O	1050	1059	abundance	abundance	I-NP	NN	O	35	OBJ	O
O	O	1060	1062	of	of	B-PP	IN	O	37	NMOD	O
O	O	1063	1068	mRNAs	mRNA	B-NP	NNS	B-RNA	38	PMOD	B-RNA
O	O	1069	1077	encoding	encode	B-VP	VBG	O	39	NMOD	O
O	O	1078	1081	the	the	B-NP	DT	O	45	NMOD	O
T26	B-Entity	1082	1084	NF	NF	I-NP	NN	B-protein	45	NMOD	B-protein
T26	I-Entity	1084	1085	-	-	O	HYPH	I-protein	45	NMOD	I-protein
T26	I-Entity	1085	1091	kappaB	kappaB	B-NP	NN	I-protein	45	NMOD	I-protein
O	O	1092	1102	components	component	I-NP	NNS	O	50	NMOD	O
T14	B-Protein	1103	1104	c	c	I-NP	NN	B-protein	48	NMOD	B-protein
T14	I-Protein	1104	1105	-	-	B-NP	HYPH	I-protein	48	NMOD	I-protein
T14	I-Protein	1105	1108	Rel	Rel	I-NP	NN	I-protein	50	NMOD	I-protein
O	O	1109	1112	and	and	I-NP	CC	O	50	NMOD	O
T15	B-Protein	1113	1117	KBF1	KBF1	I-NP	NN	B-protein	40	OBJ	B-protein
O	O	1118	1120	in	in	B-PP	IN	O	37	NMOD	O
O	O	1121	1126	these	these	B-NP	DT	O	53	NMOD	O
O	O	1127	1132	cells	cell	I-NP	NNS	O	51	PMOD	O
O	O	1132	1133	.	.	O	.	O	6	P	O

T16	B-Protein	1134	1136	IL	IL	B-NP	NN	B-protein	5	NMOD	B-protein
T16	I-Protein	1136	1137	-	-	I-NP	HYPH	I-protein	1	NMOD	I-protein
T16	I-Protein	1137	1138	2	2	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	1139	1146	binding	binding	I-NP	NN	O	5	NMOD	O
O	O	1147	1155	analysis	analysis	I-NP	NN	O	6	SUB	O
O	O	1156	1168	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	1169	1173	that	that	B-SBAR	IN	O	6	VMOD	O
T17	B-Protein	1174	1176	IL	IL	B-NP	NN	B-protein	12	SUB	B-protein
T17	I-Protein	1176	1177	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T17	I-Protein	1177	1178	2	2	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	1179	1187	markedly	markedly	B-ADVP	RB	O	12	VMOD	O
O	O	1188	1197	increased	increase	B-VP	VBD	O	7	SBAR	O
O	O	1198	1201	the	the	B-NP	DT	O	14	NMOD	O
O	O	1202	1208	number	number	I-NP	NN	O	12	OBJ	O
O	O	1209	1211	of	of	B-PP	IN	O	14	NMOD	O
O	O	1212	1215	low	low	B-NP	JJ	O	20	NMOD	O
O	O	1216	1224	affinity	affinity	I-NP	NN	O	20	NMOD	O
O	O	1225	1227	IL	IL	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	1227	1228	-	-	B-NP	HYPH	I-protein	20	NMOD	I-protein
O	O	1228	1231	2Rs	2R	I-NP	NNS	I-protein	15	PMOD	I-protein
O	O	1232	1234	on	on	B-PP	IN	O	14	NMOD	O
O	O	1235	1238	the	the	B-NP	DT	O	24	NMOD	O
O	O	1239	1247	leukemia	leukemia	I-NP	NN	B-cell_type	24	NMOD	B-cell_type
O	O	1248	1253	cells	cell	I-NP	NNS	I-cell_type	21	PMOD	I-cell_type
O	O	1253	1254	,	,	O	,	O	12	P	O
O	O	1255	1262	without	without	B-PP	IN	O	12	VMOD	O
O	O	1263	1265	an	an	B-NP	DT	O	28	NMOD	O
O	O	1266	1272	effect	effect	I-NP	NN	O	26	PMOD	O
O	O	1273	1275	on	on	B-PP	IN	O	28	NMOD	O
O	O	1276	1279	the	the	B-NP	DT	O	31	NMOD	O
O	O	1280	1286	number	number	I-NP	NN	O	29	PMOD	O
O	O	1287	1289	of	of	B-PP	IN	O	31	NMOD	O
O	O	1290	1294	high	high	B-NP	JJ	B-protein	38	NMOD	B-protein
O	O	1294	1295	-	-	I-NP	HYPH	I-protein	38	NMOD	I-protein
O	O	1295	1303	affinity	affinity	I-NP	NN	I-protein	38	NMOD	I-protein
O	O	1304	1306	IL	IL	I-NP	NN	I-protein	38	NMOD	I-protein
O	O	1306	1307	-	-	B-NP	HYPH	I-protein	38	NMOD	I-protein
O	O	1307	1310	2Rs	2R	I-NP	NNS	I-protein	32	PMOD	I-protein
O	O	1310	1311	.	.	O	.	O	6	P	O

O	O	1312	1317	These	These	B-NP	DT	O	2	NMOD	O
O	O	1318	1325	results	result	I-NP	NNS	O	3	SUB	O
O	O	1326	1330	show	show	B-VP	VBP	O	0	ROOT	O
O	O	1331	1335	that	that	B-SBAR	IN	O	29	DEP	O
T18	B-Protein	1336	1338	IL	IL	B-NP	NN	B-protein	8	SUB	B-protein
T18	I-Protein	1338	1339	-	-	O	HYPH	I-protein	5	NMOD	I-protein
T18	I-Protein	1339	1340	2	2	B-NP	CD	I-protein	5	NMOD	I-protein
O	O	1341	1343	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	1344	1351	capable	capable	B-ADJP	JJ	O	8	PRD	O
O	O	1352	1354	of	of	B-PP	IN	O	9	AMOD	O
O	O	1355	1363	inducing	induce	B-VP	VBG	O	10	PMOD	O
O	O	1364	1367	the	the	B-NP	DT	O	14	NMOD	O
O	O	1368	1375	nuclear	nuclear	I-NP	JJ	O	14	NMOD	O
O	O	1376	1386	expression	expression	I-NP	NN	O	11	OBJ	O
O	O	1387	1389	of	of	B-PP	IN	O	14	NMOD	O
T27	B-Entity	1390	1392	NF	NF	B-NP	NN	B-protein	18	NMOD	B-protein
T27	I-Entity	1392	1393	-	-	O	HYPH	I-protein	18	NMOD	I-protein
T27	I-Entity	1393	1399	kappaB	kappaB	B-NP	NN	I-protein	15	PMOD	I-protein
O	O	1400	1402	in	in	B-PP	IN	O	14	NMOD	O
O	O	1403	1410	primary	primary	B-NP	JJ	B-cell_type	26	NMOD	B-cell_type
T28	B-Entity	1411	1414	CD8	CD8	I-NP	NN	I-cell_type	26	NMOD	I-cell_type
O	O	1414	1415	+	+	B-NP	SYM	I-cell_type	26	NMOD	I-cell_type
O	O	1416	1417	T	T	I-NP	NN	I-cell_type	26	NMOD	I-cell_type
O	O	1417	1418	-	-	I-NP	HYPH	I-cell_type	26	NMOD	I-cell_type
O	O	1418	1421	PLL	PLL	I-NP	NN	I-cell_type	26	NMOD	I-cell_type
O	O	1422	1427	cells	cell	I-NP	NNS	I-cell_type	19	PMOD	I-cell_type
O	O	1427	1428	,	,	O	,	O	29	P	O
O	O	1429	1432	and	and	O	CC	O	29	DEP	O
O	O	1433	1437	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1438	1442	this	this	B-NP	DT	O	31	NMOD	O
O	O	1443	1449	effect	effect	I-NP	NN	O	32	SUB	O
O	O	1450	1452	is	be	B-VP	VBZ	O	29	SBAR	O
O	O	1453	1461	mediated	mediate	I-VP	VBN	O	32	VC	O
O	O	1461	1462	,	,	O	,	O	33	P	O
O	O	1463	1465	at	at	B-ADVP	IN	O	37	PMOD	O
O	O	1466	1471	least	least	I-ADVP	JJS	O	35	AMOD	O
O	O	1472	1474	in	in	B-PP	IN	O	33	VMOD	O
O	O	1475	1479	part	part	B-NP	NN	O	37	PMOD	O
O	O	1479	1480	,	,	O	,	O	33	P	O
O	O	1481	1483	at	at	B-PP	IN	O	33	VMOD	O
O	O	1484	1485	a	a	B-NP	DT	O	43	NMOD	O
O	O	1486	1502	pretranslational	pretranslational	I-NP	JJ	O	43	NMOD	O
O	O	1503	1508	level	level	I-NP	NN	O	40	PMOD	O
O	O	1508	1509	.	.	O	.	O	3	P	O
